Status:
RECRUITING
Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung Cancer
Lead Sponsor:
Qilu Hospital of Shandong University
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
Brief Summary
Mediastinal lymph node metastasis is a common metastasis pathway of non-small cell lung cancer (NSCLC), and its occurrence is closely related to the lymphatic drainage pattern, which is different in d...
Detailed Description
Background: Lung cancer is one of the malignant tumors with the highest morbidity and mortality in the world. non-small cell lung carcinoma (NSCLC) accounts for about 85% of lung cancer, and its 5-yea...
Eligibility Criteria
Inclusion
- Surgical resection and systematic lymph node dissection were performed in the department of thoracic surgery, and the postoperative pathological findings were confirmed as NSCLC and complete pathological diagnostic data were retained.
- Chest CT enhancement scan was completed within 2 weeks prior to surgery
- Image quality meets analysis standards and clinical data is complete.
- Lymph nodes that were pathologically confirmed to be metastatic or non-metastatic at station 4 were selected
Exclusion
- Preoperative chemoradiotherapy or other treatment
- Distant metastasis or other malignant tumors are present
- Incomplete clinical data or image artifacts
- No metastatic or non-metastatic lymph nodes were found at station 4
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06496360
Start Date
August 1 2024
End Date
June 1 2025
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250063